The AKR1B10 expression was markedly down-regulated in metastatic lesions compared to primary tumors, as evidenced by analyses of the colon adenocarcinoma (COAD)–GEO dataset and our independent cohort (Fig. 2, O to Q). This evidence concerns the gene AKR1B10 and colon adenocarcinoma.